Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability.
about
Italian guidelines for primary headaches: 2012 revised versionTreating headache recurrence after emergency department discharge: a randomized controlled trial of naproxen versus sumatriptan.Fixed-dose Sumatriptan/Naproxen Sodium Compared with each Monotherapy Utilizing the Novel Composite Endpoint of Sustained Pain-free/no Adverse Events.Acute Migraine Treatment in Adults.Why pharmacokinetic differences among oral triptans have little clinical importance: a comment.A review of the use of frovatriptan in the treatment of menstrually related migraine.Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine.Efficacy of (S)-Lacosamide in preclinical models of cephalic pain.Manage migraine with acupuncture: a review of acupuncture protocols in randomized controlled trials.Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment.Understanding migraine as a cycling brain syndrome: reviewing the evidence from functional imaging.Quantifying the return of headache in triptan-treated migraineurs: an observational study.Pattern of triptan use and cardiovascular coprescription: a pharmacoepidemiological study in Italy.Use of 5-HT1 agonists in pregnancy.Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.Overview of migraine treatment.Acupuncture therapy in treating migraine: results of a magnetic resonance spectroscopy imaging study.Application of the BRAT Framework to Case Studies: Observations and Insights
P2860
Q30466790-5FC1C153-A06D-4684-9F7B-5AC8074BA927Q33987376-30150939-F54E-479B-AEF9-CB61C7081BE6Q34409359-F1E5739E-50AD-4A5A-80CC-227110C8D731Q34471863-24E24F78-971E-46C8-A936-3FD4EB7FECCEQ34770884-1625A6B4-17EB-4FEF-9EEA-AA8507285B53Q36638660-F84FBB20-B391-49DD-A58C-2A68162C08DBQ37154795-438246F8-582F-4486-B5D7-21D4056142EEQ37451570-2821BCAE-4382-456E-B90D-91EA03590909Q37772153-3C2E4EE1-9C1D-49E0-9C0D-658C6CCA0E6AQ37847067-FE7DB19B-1381-400F-A6ED-DB4F98789DB9Q38773589-5AA999CC-CB4B-48BC-8FD8-5F010C013500Q42963776-689A5752-D0BB-475F-8CAF-094D70CB85BCQ44895375-5DBB26C6-BA5C-48E8-BDE2-42F255D8B668Q45112419-9C9471DF-FBBE-481E-8B9F-22CC0B27C1E9Q45848154-590D2BBF-9F45-4C49-95A3-F7AF55ACF4ACQ46098987-FC9B3AD6-7925-4522-8FF4-3AF069CDCA6CQ55031002-44D5E5CD-DC45-4852-A4F8-B5D49E1528A0Q57847675-1E7031FB-D253-4164-B898-F40758EFB658
P2860
Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Marketed oral triptans in the ...... on efficacy and tolerability.
@ast
Marketed oral triptans in the ...... on efficacy and tolerability.
@en
Marketed oral triptans in the ...... on efficacy and tolerability.
@nl
type
label
Marketed oral triptans in the ...... on efficacy and tolerability.
@ast
Marketed oral triptans in the ...... on efficacy and tolerability.
@en
Marketed oral triptans in the ...... on efficacy and tolerability.
@nl
prefLabel
Marketed oral triptans in the ...... on efficacy and tolerability.
@ast
Marketed oral triptans in the ...... on efficacy and tolerability.
@en
Marketed oral triptans in the ...... on efficacy and tolerability.
@nl
P2093
P2860
P1433
P1476
Marketed oral triptans in the ...... on efficacy and tolerability.
@en
P2093
Carles Roig
Dolores Jiménez
Julio Pascual
Margarita Sanchez-Del-Rio
Valentin Mateos
P2860
P304
P356
10.1111/J.1526-4610.2007.00849.X
P577
2007-09-01T00:00:00Z